Rippin, Gerd https://orcid.org/0000-0001-6293-8465
Sanz, Héctor
Hoogendoorn, Wilhelmina E.
Ballarini, Nicolás M.
Largent, Joan A.
Demas, Eleni
Postmus, Douwe
Framke, Theodor
Dávila, Lukas M. Aguirre
Quinten, Chantal
Pignatti, Francesco
Funding for this research was provided by:
European Medicines Agency (EMA/2017/09/PE, Lot 4)
Article History
Accepted: 4 July 2024
First Online: 5 August 2024
Declarations
:
: This work was funded by the European Medicines Agency (EMA/2017/09/PE, Lot 4).
: The authors have no conflicts of interests that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Randomised controlled trial data sharing is not permitted by the policies of Project Data Sphere, LLC [] and Yale Open Data Access [], which had to be signed by IQVIA at the start of this research project.
: The programming code for simulations is available in the ESM.
: The main author directed all research efforts and drafted the first version of the publication. Contributing authors revised and added to the first version. Each author had participated sufficiently in the work to take responsibility of portions of the content. All authors read and approved the final manuscript.
: The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory agency/agencies or organisations with which the authors are employed/affiliated.